ANTIMIKROBIELLE VERBINDUNGEN

Patent europeic · EP2235041 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2235041
Numer da la dumonda
EP08865440
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
22-12-2008
Publitgà
06-10-2010
Concedì
05-03-2014
La protecziun finescha il pli tard
21-12-2028
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
C07K 5/08 (2006.01)
A61K 38/06 (2006.01)
A61P 31/04 (2006.01)
Prioritad
GB 0724951 20.12.2007
Dumonda PCT
PCT/GB2008/004245 22.12.2008
Publicaziun PCT
WO2009/081152 02.07.2009
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-01-2026

    Midada

    Published in Swissreg on 01.01.2026

  2. 01-01-2025

    Midada

    Published in Swissreg on 01.01.2025

  3. 01-01-2024

    Midada

    Published in Swissreg on 01.01.2024

  4. 01-01-2023

    Midada

    Published in Swissreg on 01.01.2023

  5. 03-08-2021

    Transferì

    Owner
    Lytix Biopharma AS, Tromsø Science Park, P.O. Box 6447, 9294 Tromsø, Norway → Peptide Patents AS, Sykehusvegen 23, 9019 Tromsø, Norway

    Published in Swissreg on 03.08.2021

  6. 05-03-2014

    Concedì

    Published in Swissreg on 05.03.2014

Partidas

Possessur

Peptide Patents AS

Sykehusvegen 23, 9019 Tromsø, NO

Inventur

STENSEN, Wenche

N-9100 Kvaløysletta, NO

HAUG, Bengt, Erik

N-5114 Tertnes, NO

REKDAL, Øystein

N-1395 Hvalstad, NO

SVENDSEN, John, Sigurd

N-9100 Kvaløysletta, NO

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.